Fig. 3

Clinical significance of CYFIP2. A CYFIP2 expression levels in tumor tissues and corresponding normal tissues in different cancer types from TCGA data in TIMER 2.0. *P < 0.05, **P < 0.01, ***P < 0.001. B CYFIP2 expression levels in LUAD and normal tissues. C CYFIP2 expression levels in LUAD and its paired adjacent tissues D Receiver operating characteristic analysis of CYFIP2 in LUAD based on TCGA data. E Receiver operating characteristic analysis of CYFIP2 in LUAD by combining TCGA and GTEx data. F–J Association between the CYFIP2 expression and different clinicopathological characteristics in TCGA-LUAD cohort